ReviewJournal of pain research2017

Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab.

Maria Adele Giamberardino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.